Editas Medicine (0IFK.L) Stock Price

$1.21 4.3%

Sign up
to add to portfolio

AI Score

Sell
  • Alternative

    3
  • Fundamental

    0
  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Editas Medicine, AI stock picks, stock alerts and much more.

Sign up

0IFK.L AI Stock Analysis

AI stock analysis for 0IFK.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Editas Medicine (0IFK.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Editas Medicine (0IFK.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Editas Medicine (0IFK.L), currently trading at $1.21, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About 0IFK.L

LSE
  • Editas Medicine, Inc.

  • Symbol

    0IFK.L

  • Market

    LSE

  • Industry

    Medical - Pharmaceuticals

  • Market Cap

    99.9M

0IFK.L Alternative Data

Web Traffic

Editas Medicine receives an estimated 17470 monthly visitors to editasmedicine.com, which is down by -15.9% over the last month.

  • Web Traffic

    17470

  • Change from Previous Month

    15.9%

  • 3 Month Change

    45.6%

News Mentions

Editas Medicine was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    100%

  • 3 Month Change

    0%

Twitter Followers

Editas Medicine has 8,175 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.

  • Twitter Followers

    8175

  • Daily Change

    0%

  • 1 Month Change

    0.2%

  • 3 Month Change

    0.3%

Instagram Followers

Editas Medicine has 28 Instagram Followers on its main Instagram account.

  • Instagram Followers

    28

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Followers

47,486 are following Editas Medicine on LinkedIn, up by 0.6% over the last month.

  • LinkedIn Followers

    47486

  • Daily Change

    0%

  • 1 Month Change

    0.6%

  • 3 Month Change

    1.4%

Job Postings

Editas Medicine currenly has an estimated 1 open job postings.

  • Job Postings

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    90.9%

LinkedIn Employees

According to LinkedIn, Editas Medicine has 323 employees, down by -1.8% over the last month.

  • LinkedIn Employees

    323

  • Daily Change

    0%

  • 1 Month Change

    1.8%

  • 3 Month Change

    3.9%

Business Outlook
  • Business Outlook

    52

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

0IFK.L Financials

0IFK.L Key Metrics
  • Total Revenue

    $61K

  • Net Income

    -$62.1M

  • Earnings per Share

    -$0.75

  • Free cash flow

    -$55.5M

  • EBITDA

    -$62.1M

  • EBITDA Ratio

    -1018.7

  • Total Assets

    $327.6M

0IFK.L 2-year Revenue & Income
0IFK.L 2-year Free Cash Flow

0IFK.L Technicals

0IFK.L SMA
0IFK.L RSI

FAQ

What's the current price of Editas Medicine (0IFK.L) Stock?
The price of an Editas Medicine (0IFK.L) share is $1.21.

What's the market cap of Editas Medicine?
The current market cap of Editas Medicine is 99.9M.

Should I buy or sell 0IFK.L?
Editas Medicine exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is Editas Medicine a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Editas Medicine stock. There are several bearish signals and market challenges that could negatively impact Editas Medicine's future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy Editas Medicine (0IFK.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Editas Medicine stock right now, as the outlook appears bearish.

What are some stocks similar to Editas Medicine (0IFK.L) that investors often compare it to?
Editas Medicine (0IFK.L) is often compared to similar stocks such as Waters Corporation, Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc. and Abeona Therapeutics Inc..

What is the forecast for Editas Medicine's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Editas Medicine's stock price to be around $1.03 in 2026. Starting from the current price of $1.21, this represents a 15.1% change in price, indicating a bearish outlook for the stock.

How to buy Editas Medicine (0IFK.L) Stock?
Editas Medicine stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Editas Medicine shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.